nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—ESR2—uterine cancer	0.199	0.619	CbGaD
Estropipate—Formestane—Progesterone—uterine cancer	0.179	1	CrCrCtD
Estropipate—ESR1—uterine cancer	0.123	0.381	CbGaD
Estropipate—SHBG—Medroxyprogesterone Acetate—uterine cancer	0.0938	0.275	CbGbCtD
Estropipate—ESR1—Medroxyprogesterone Acetate—uterine cancer	0.0678	0.199	CbGbCtD
Estropipate—SHBG—Progesterone—uterine cancer	0.0621	0.182	CbGbCtD
Estropipate—ESR1—Progesterone—uterine cancer	0.0449	0.132	CbGbCtD
Estropipate—SLC22A1—Progesterone—uterine cancer	0.0251	0.0736	CbGbCtD
Estropipate—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.012	0.0351	CbGbCtD
Estropipate—CYP1A2—Progesterone—uterine cancer	0.0088	0.0258	CbGbCtD
Estropipate—CYP2C9—Progesterone—uterine cancer	0.00793	0.0232	CbGbCtD
Estropipate—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00696	0.0204	CbGbCtD
Estropipate—CYP3A4—Progesterone—uterine cancer	0.00461	0.0135	CbGbCtD
Estropipate—CYP1A2—Etoposide—uterine cancer	0.00394	0.0115	CbGbCtD
Estropipate—SHBG—semen—uterine cancer	0.0031	0.155	CbGeAlD
Estropipate—ESR2—oviduct—uterine cancer	0.00234	0.117	CbGeAlD
Estropipate—CYP3A4—Etoposide—uterine cancer	0.00206	0.00605	CbGbCtD
Estropipate—ESR1—oviduct—uterine cancer	0.0016	0.08	CbGeAlD
Estropipate—CYP3A4—Doxorubicin—uterine cancer	0.00141	0.00412	CbGbCtD
Estropipate—ESR2—epithelium—uterine cancer	0.000587	0.0293	CbGeAlD
Estropipate—ESR2—uterine cervix—uterine cancer	0.000582	0.0291	CbGeAlD
Estropipate—ESR2—smooth muscle tissue—uterine cancer	0.000566	0.0283	CbGeAlD
Estropipate—ESR2—renal system—uterine cancer	0.000545	0.0272	CbGeAlD
Estropipate—ESR2—endometrium—uterine cancer	0.000526	0.0263	CbGeAlD
Estropipate—ESR1—myometrium—uterine cancer	0.000512	0.0256	CbGeAlD
Estropipate—SHBG—endometrium—uterine cancer	0.000512	0.0256	CbGeAlD
Estropipate—ESR2—uterus—uterine cancer	0.000485	0.0242	CbGeAlD
Estropipate—SHBG—uterus—uterine cancer	0.000472	0.0236	CbGeAlD
Estropipate—SLC22A1—renal system—uterine cancer	0.000457	0.0228	CbGeAlD
Estropipate—ESR2—female reproductive system—uterine cancer	0.000436	0.0218	CbGeAlD
Estropipate—SHBG—female reproductive system—uterine cancer	0.000424	0.0212	CbGeAlD
Estropipate—ESR1—epithelium—uterine cancer	0.000402	0.0201	CbGeAlD
Estropipate—ESR1—uterine cervix—uterine cancer	0.000399	0.0199	CbGeAlD
Estropipate—ESR2—female gonad—uterine cancer	0.000397	0.0198	CbGeAlD
Estropipate—ESR2—vagina—uterine cancer	0.000394	0.0197	CbGeAlD
Estropipate—ESR1—smooth muscle tissue—uterine cancer	0.000387	0.0194	CbGeAlD
Estropipate—SHBG—female gonad—uterine cancer	0.000386	0.0193	CbGeAlD
Estropipate—SHBG—vagina—uterine cancer	0.000383	0.0191	CbGeAlD
Estropipate—ESR1—decidua—uterine cancer	0.00038	0.019	CbGeAlD
Estropipate—ESR1—renal system—uterine cancer	0.000373	0.0186	CbGeAlD
Estropipate—ESR1—endometrium—uterine cancer	0.000361	0.018	CbGeAlD
Estropipate—Estriol—ESR2—uterine cancer	0.000344	0.116	CrCbGaD
Estropipate—ESR1—uterus—uterine cancer	0.000332	0.0166	CbGeAlD
Estropipate—SLC22A1—vagina—uterine cancer	0.000331	0.0165	CbGeAlD
Estropipate—Quinestrol—ESR1—uterine cancer	0.000321	0.108	CrCbGaD
Estropipate—Estramustine—ESR2—uterine cancer	0.00032	0.108	CrCbGaD
Estropipate—ESR1—female reproductive system—uterine cancer	0.000299	0.0149	CbGeAlD
Estropipate—Exemestane—CYP19A1—uterine cancer	0.000296	0.0998	CrCbGaD
Estropipate—CYP1A2—renal system—uterine cancer	0.000288	0.0144	CbGeAlD
Estropipate—ESR1—female gonad—uterine cancer	0.000272	0.0136	CbGeAlD
Estropipate—ESR1—vagina—uterine cancer	0.00027	0.0135	CbGeAlD
Estropipate—ESR2—lymph node—uterine cancer	0.000255	0.0127	CbGeAlD
Estropipate—Mestranol—ESR1—uterine cancer	0.000243	0.0819	CrCbGaD
Estropipate—CYP2C9—female reproductive system—uterine cancer	0.000219	0.0109	CbGeAlD
Estropipate—Estriol—ESR1—uterine cancer	0.000212	0.0715	CrCbGaD
Estropipate—CYP3A4—renal system—uterine cancer	0.000208	0.0104	CbGeAlD
Estropipate—ALB—lymph node—uterine cancer	0.000205	0.0102	CbGeAlD
Estropipate—Estramustine—ESR1—uterine cancer	0.000197	0.0664	CrCbGaD
Estropipate—Ethinyl Estradiol—ESR2—uterine cancer	0.000188	0.0634	CrCbGaD
Estropipate—ESR1—lymph node—uterine cancer	0.000175	0.00873	CbGeAlD
Estropipate—CYP3A4—female reproductive system—uterine cancer	0.000167	0.00832	CbGeAlD
Estropipate—Conjugated Estrogens—ESR2—uterine cancer	0.000164	0.0553	CrCbGaD
Estropipate—Estrone—ESR2—uterine cancer	0.000164	0.0552	CrCbGaD
Estropipate—Estradiol—ESR2—uterine cancer	0.000124	0.0418	CrCbGaD
Estropipate—Ethinyl Estradiol—ESR1—uterine cancer	0.000116	0.039	CrCbGaD
Estropipate—Conjugated Estrogens—ESR1—uterine cancer	0.000101	0.0341	CrCbGaD
Estropipate—Estrone—ESR1—uterine cancer	0.000101	0.034	CrCbGaD
Estropipate—Estradiol—ESR1—uterine cancer	7.65e-05	0.0258	CrCbGaD
Estropipate—Fatigue—Medroxyprogesterone Acetate—uterine cancer	6.21e-05	0.000522	CcSEcCtD
Estropipate—Cystitis—Epirubicin—uterine cancer	6.17e-05	0.000519	CcSEcCtD
Estropipate—Constipation—Medroxyprogesterone Acetate—uterine cancer	6.16e-05	0.000518	CcSEcCtD
Estropipate—Inflammation—Doxorubicin—uterine cancer	6.1e-05	0.000512	CcSEcCtD
Estropipate—Fluid retention—Epirubicin—uterine cancer	6.07e-05	0.00051	CcSEcCtD
Estropipate—Vaginal infection—Epirubicin—uterine cancer	6.04e-05	0.000507	CcSEcCtD
Estropipate—Hepatobiliary disease—Etoposide—uterine cancer	6.03e-05	0.000507	CcSEcCtD
Estropipate—Musculoskeletal pain—Doxorubicin—uterine cancer	5.99e-05	0.000503	CcSEcCtD
Estropipate—Vaginal inflammation—Doxorubicin—uterine cancer	5.92e-05	0.000497	CcSEcCtD
Estropipate—Pulmonary embolism—Doxorubicin—uterine cancer	5.92e-05	0.000497	CcSEcCtD
Estropipate—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	5.89e-05	0.000495	CcSEcCtD
Estropipate—Cramps of lower extremities—Epirubicin—uterine cancer	5.87e-05	0.000493	CcSEcCtD
Estropipate—Myalgia—Dactinomycin—uterine cancer	5.86e-05	0.000493	CcSEcCtD
Estropipate—Hypersensitivity—Progesterone—uterine cancer	5.86e-05	0.000492	CcSEcCtD
Estropipate—Neoplasm—Epirubicin—uterine cancer	5.78e-05	0.000486	CcSEcCtD
Estropipate—Bladder pain—Epirubicin—uterine cancer	5.78e-05	0.000486	CcSEcCtD
Estropipate—Cystitis noninfective—Doxorubicin—uterine cancer	5.78e-05	0.000485	CcSEcCtD
Estropipate—Urticaria—Medroxyprogesterone Acetate—uterine cancer	5.73e-05	0.000481	CcSEcCtD
Estropipate—Cystitis—Doxorubicin—uterine cancer	5.71e-05	0.00048	CcSEcCtD
Estropipate—Asthenia—Progesterone—uterine cancer	5.71e-05	0.000479	CcSEcCtD
Estropipate—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	5.7e-05	0.000479	CcSEcCtD
Estropipate—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	5.7e-05	0.000479	CcSEcCtD
Estropipate—Pruritus—Progesterone—uterine cancer	5.63e-05	0.000473	CcSEcCtD
Estropipate—Oedema—Dactinomycin—uterine cancer	5.62e-05	0.000472	CcSEcCtD
Estropipate—Fluid retention—Doxorubicin—uterine cancer	5.62e-05	0.000472	CcSEcCtD
Estropipate—Hypertonia—Epirubicin—uterine cancer	5.6e-05	0.000471	CcSEcCtD
Estropipate—Infection—Dactinomycin—uterine cancer	5.59e-05	0.000469	CcSEcCtD
Estropipate—Vaginal infection—Doxorubicin—uterine cancer	5.58e-05	0.000469	CcSEcCtD
Estropipate—Diarrhoea—Progesterone—uterine cancer	5.44e-05	0.000457	CcSEcCtD
Estropipate—Cramps of lower extremities—Doxorubicin—uterine cancer	5.43e-05	0.000457	CcSEcCtD
Estropipate—Erythema multiforme—Etoposide—uterine cancer	5.42e-05	0.000455	CcSEcCtD
Estropipate—Thrombophlebitis—Epirubicin—uterine cancer	5.36e-05	0.00045	CcSEcCtD
Estropipate—Eye disorder—Etoposide—uterine cancer	5.35e-05	0.00045	CcSEcCtD
Estropipate—Bladder pain—Doxorubicin—uterine cancer	5.35e-05	0.000449	CcSEcCtD
Estropipate—Neoplasm—Doxorubicin—uterine cancer	5.35e-05	0.000449	CcSEcCtD
Estropipate—Cardiac disorder—Etoposide—uterine cancer	5.32e-05	0.000447	CcSEcCtD
Estropipate—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	5.31e-05	0.000446	CcSEcCtD
Estropipate—Hepatic function abnormal—Epirubicin—uterine cancer	5.31e-05	0.000446	CcSEcCtD
Estropipate—Dizziness—Progesterone—uterine cancer	5.26e-05	0.000442	CcSEcCtD
Estropipate—Angiopathy—Etoposide—uterine cancer	5.2e-05	0.000437	CcSEcCtD
Estropipate—Hypertonia—Doxorubicin—uterine cancer	5.19e-05	0.000436	CcSEcCtD
Estropipate—Immune system disorder—Etoposide—uterine cancer	5.17e-05	0.000435	CcSEcCtD
Estropipate—Asthenia—Medroxyprogesterone Acetate—uterine cancer	5.17e-05	0.000434	CcSEcCtD
Estropipate—Mediastinal disorder—Etoposide—uterine cancer	5.16e-05	0.000434	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Dactinomycin—uterine cancer	5.12e-05	0.00043	CcSEcCtD
Estropipate—Pruritus—Medroxyprogesterone Acetate—uterine cancer	5.1e-05	0.000428	CcSEcCtD
Estropipate—Alopecia—Etoposide—uterine cancer	5.06e-05	0.000425	CcSEcCtD
Estropipate—Vomiting—Progesterone—uterine cancer	5.06e-05	0.000425	CcSEcCtD
Estropipate—Rash—Progesterone—uterine cancer	5.02e-05	0.000421	CcSEcCtD
Estropipate—Dermatitis—Progesterone—uterine cancer	5.01e-05	0.000421	CcSEcCtD
Estropipate—Headache—Progesterone—uterine cancer	4.98e-05	0.000419	CcSEcCtD
Estropipate—Thrombophlebitis—Doxorubicin—uterine cancer	4.96e-05	0.000417	CcSEcCtD
Estropipate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	4.93e-05	0.000414	CcSEcCtD
Estropipate—Hepatic function abnormal—Doxorubicin—uterine cancer	4.91e-05	0.000413	CcSEcCtD
Estropipate—Dermatitis bullous—Epirubicin—uterine cancer	4.86e-05	0.000408	CcSEcCtD
Estropipate—Fatigue—Dactinomycin—uterine cancer	4.85e-05	0.000407	CcSEcCtD
Estropipate—Back pain—Etoposide—uterine cancer	4.82e-05	0.000405	CcSEcCtD
Estropipate—Purpura—Epirubicin—uterine cancer	4.81e-05	0.000404	CcSEcCtD
Estropipate—Pain—Dactinomycin—uterine cancer	4.81e-05	0.000404	CcSEcCtD
Estropipate—Anaphylactoid reaction—Epirubicin—uterine cancer	4.79e-05	0.000403	CcSEcCtD
Estropipate—Muscle spasms—Etoposide—uterine cancer	4.79e-05	0.000403	CcSEcCtD
Estropipate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	4.77e-05	0.0004	CcSEcCtD
Estropipate—Cerebrovascular accident—Epirubicin—uterine cancer	4.74e-05	0.000398	CcSEcCtD
Estropipate—Nausea—Progesterone—uterine cancer	4.72e-05	0.000397	CcSEcCtD
Estropipate—Pain in extremity—Epirubicin—uterine cancer	4.64e-05	0.00039	CcSEcCtD
Estropipate—Gastrointestinal pain—Dactinomycin—uterine cancer	4.6e-05	0.000386	CcSEcCtD
Estropipate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	4.58e-05	0.000385	CcSEcCtD
Estropipate—Migraine—Epirubicin—uterine cancer	4.57e-05	0.000384	CcSEcCtD
Estropipate—Rash—Medroxyprogesterone Acetate—uterine cancer	4.54e-05	0.000382	CcSEcCtD
Estropipate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	4.54e-05	0.000381	CcSEcCtD
Estropipate—Headache—Medroxyprogesterone Acetate—uterine cancer	4.52e-05	0.000379	CcSEcCtD
Estropipate—Dermatitis bullous—Doxorubicin—uterine cancer	4.49e-05	0.000377	CcSEcCtD
Estropipate—Vertigo—Etoposide—uterine cancer	4.48e-05	0.000376	CcSEcCtD
Estropipate—Purpura—Doxorubicin—uterine cancer	4.46e-05	0.000374	CcSEcCtD
Estropipate—Abdominal pain—Dactinomycin—uterine cancer	4.44e-05	0.000373	CcSEcCtD
Estropipate—Body temperature increased—Dactinomycin—uterine cancer	4.44e-05	0.000373	CcSEcCtD
Estropipate—Anaphylactoid reaction—Doxorubicin—uterine cancer	4.44e-05	0.000373	CcSEcCtD
Estropipate—Mood swings—Epirubicin—uterine cancer	4.4e-05	0.000369	CcSEcCtD
Estropipate—Cerebrovascular accident—Doxorubicin—uterine cancer	4.38e-05	0.000368	CcSEcCtD
Estropipate—Cough—Etoposide—uterine cancer	4.35e-05	0.000365	CcSEcCtD
Estropipate—Pain in extremity—Doxorubicin—uterine cancer	4.29e-05	0.000361	CcSEcCtD
Estropipate—Nausea—Medroxyprogesterone Acetate—uterine cancer	4.28e-05	0.00036	CcSEcCtD
Estropipate—Migraine—Doxorubicin—uterine cancer	4.23e-05	0.000355	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	4.22e-05	0.000354	CcSEcCtD
Estropipate—Breast disorder—Epirubicin—uterine cancer	4.19e-05	0.000352	CcSEcCtD
Estropipate—Hypersensitivity—Dactinomycin—uterine cancer	4.14e-05	0.000348	CcSEcCtD
Estropipate—Anaphylactic shock—Etoposide—uterine cancer	4.07e-05	0.000342	CcSEcCtD
Estropipate—Mood swings—Doxorubicin—uterine cancer	4.07e-05	0.000342	CcSEcCtD
Estropipate—Infection—Etoposide—uterine cancer	4.04e-05	0.00034	CcSEcCtD
Estropipate—Abdominal distension—Epirubicin—uterine cancer	4.04e-05	0.000339	CcSEcCtD
Estropipate—Asthenia—Dactinomycin—uterine cancer	4.03e-05	0.000339	CcSEcCtD
Estropipate—Asthma—Epirubicin—uterine cancer	4.01e-05	0.000337	CcSEcCtD
Estropipate—Influenza—Epirubicin—uterine cancer	4.01e-05	0.000337	CcSEcCtD
Estropipate—Skin disorder—Etoposide—uterine cancer	3.95e-05	0.000332	CcSEcCtD
Estropipate—Pancreatitis—Epirubicin—uterine cancer	3.93e-05	0.00033	CcSEcCtD
Estropipate—Breast disorder—Doxorubicin—uterine cancer	3.88e-05	0.000326	CcSEcCtD
Estropipate—Diarrhoea—Dactinomycin—uterine cancer	3.85e-05	0.000323	CcSEcCtD
Estropipate—Dysuria—Epirubicin—uterine cancer	3.75e-05	0.000315	CcSEcCtD
Estropipate—Abdominal distension—Doxorubicin—uterine cancer	3.74e-05	0.000314	CcSEcCtD
Estropipate—Upper respiratory tract infection—Epirubicin—uterine cancer	3.73e-05	0.000313	CcSEcCtD
Estropipate—Asthma—Doxorubicin—uterine cancer	3.71e-05	0.000312	CcSEcCtD
Estropipate—Influenza—Doxorubicin—uterine cancer	3.71e-05	0.000312	CcSEcCtD
Estropipate—Paraesthesia—Etoposide—uterine cancer	3.65e-05	0.000307	CcSEcCtD
Estropipate—Weight increased—Epirubicin—uterine cancer	3.65e-05	0.000307	CcSEcCtD
Estropipate—Pancreatitis—Doxorubicin—uterine cancer	3.64e-05	0.000306	CcSEcCtD
Estropipate—Hyperglycaemia—Epirubicin—uterine cancer	3.62e-05	0.000304	CcSEcCtD
Estropipate—Somnolence—Etoposide—uterine cancer	3.62e-05	0.000304	CcSEcCtD
Estropipate—Infestation NOS—Epirubicin—uterine cancer	3.58e-05	0.0003	CcSEcCtD
Estropipate—Infestation—Epirubicin—uterine cancer	3.58e-05	0.0003	CcSEcCtD
Estropipate—Vomiting—Dactinomycin—uterine cancer	3.57e-05	0.0003	CcSEcCtD
Estropipate—Rash—Dactinomycin—uterine cancer	3.54e-05	0.000298	CcSEcCtD
Estropipate—Gastrointestinal disorder—Etoposide—uterine cancer	3.51e-05	0.000295	CcSEcCtD
Estropipate—Fatigue—Etoposide—uterine cancer	3.51e-05	0.000295	CcSEcCtD
Estropipate—Neuropathy peripheral—Epirubicin—uterine cancer	3.51e-05	0.000294	CcSEcCtD
Estropipate—Pain—Etoposide—uterine cancer	3.48e-05	0.000292	CcSEcCtD
Estropipate—Constipation—Etoposide—uterine cancer	3.48e-05	0.000292	CcSEcCtD
Estropipate—Dysuria—Doxorubicin—uterine cancer	3.47e-05	0.000292	CcSEcCtD
Estropipate—Upper respiratory tract infection—Doxorubicin—uterine cancer	3.45e-05	0.00029	CcSEcCtD
Estropipate—Hepatobiliary disease—Epirubicin—uterine cancer	3.38e-05	0.000284	CcSEcCtD
Estropipate—Weight increased—Doxorubicin—uterine cancer	3.38e-05	0.000284	CcSEcCtD
Estropipate—Sinusitis—Epirubicin—uterine cancer	3.36e-05	0.000282	CcSEcCtD
Estropipate—Hyperglycaemia—Doxorubicin—uterine cancer	3.35e-05	0.000281	CcSEcCtD
Estropipate—Nausea—Dactinomycin—uterine cancer	3.34e-05	0.000281	CcSEcCtD
Estropipate—Gastrointestinal pain—Etoposide—uterine cancer	3.33e-05	0.00028	CcSEcCtD
Estropipate—Infestation—Doxorubicin—uterine cancer	3.31e-05	0.000278	CcSEcCtD
Estropipate—Infestation NOS—Doxorubicin—uterine cancer	3.31e-05	0.000278	CcSEcCtD
Estropipate—Neuropathy peripheral—Doxorubicin—uterine cancer	3.24e-05	0.000272	CcSEcCtD
Estropipate—Urticaria—Etoposide—uterine cancer	3.23e-05	0.000272	CcSEcCtD
Estropipate—Rhinitis—Epirubicin—uterine cancer	3.22e-05	0.00027	CcSEcCtD
Estropipate—Abdominal pain—Etoposide—uterine cancer	3.22e-05	0.00027	CcSEcCtD
Estropipate—Body temperature increased—Etoposide—uterine cancer	3.22e-05	0.00027	CcSEcCtD
Estropipate—Pharyngitis—Epirubicin—uterine cancer	3.19e-05	0.000268	CcSEcCtD
Estropipate—Oedema peripheral—Epirubicin—uterine cancer	3.16e-05	0.000266	CcSEcCtD
Estropipate—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	3.15e-05	0.00195	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.15e-05	0.00194	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	3.15e-05	0.00194	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	3.14e-05	0.00194	CbGpPWpGaD
Estropipate—Hepatobiliary disease—Doxorubicin—uterine cancer	3.13e-05	0.000263	CcSEcCtD
Estropipate—Sinusitis—Doxorubicin—uterine cancer	3.1e-05	0.000261	CcSEcCtD
Estropipate—Visual impairment—Epirubicin—uterine cancer	3.09e-05	0.00026	CcSEcCtD
Estropipate—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	3.08e-05	0.0019	CbGpPWpGaD
Estropipate—Erythema multiforme—Epirubicin—uterine cancer	3.04e-05	0.000255	CcSEcCtD
Estropipate—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	3e-05	0.00185	CbGpPWpGaD
Estropipate—Eye disorder—Epirubicin—uterine cancer	3e-05	0.000252	CcSEcCtD
Estropipate—Hypersensitivity—Etoposide—uterine cancer	3e-05	0.000252	CcSEcCtD
Estropipate—Cardiac disorder—Epirubicin—uterine cancer	2.98e-05	0.00025	CcSEcCtD
Estropipate—Rhinitis—Doxorubicin—uterine cancer	2.98e-05	0.00025	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.97e-05	0.00184	CbGpPWpGaD
Estropipate—Pharyngitis—Doxorubicin—uterine cancer	2.95e-05	0.000248	CcSEcCtD
Estropipate—Oedema peripheral—Doxorubicin—uterine cancer	2.93e-05	0.000246	CcSEcCtD
Estropipate—Asthenia—Etoposide—uterine cancer	2.92e-05	0.000245	CcSEcCtD
Estropipate—Angiopathy—Epirubicin—uterine cancer	2.91e-05	0.000245	CcSEcCtD
Estropipate—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	2.9e-05	0.00179	CbGpPWpGaD
Estropipate—Immune system disorder—Epirubicin—uterine cancer	2.9e-05	0.000244	CcSEcCtD
Estropipate—Mediastinal disorder—Epirubicin—uterine cancer	2.89e-05	0.000243	CcSEcCtD
Estropipate—Pruritus—Etoposide—uterine cancer	2.88e-05	0.000242	CcSEcCtD
Estropipate—Visual impairment—Doxorubicin—uterine cancer	2.86e-05	0.00024	CcSEcCtD
Estropipate—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	2.86e-05	0.00177	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—CHD4—uterine cancer	2.85e-05	0.00176	CbGpPWpGaD
Estropipate—Alopecia—Epirubicin—uterine cancer	2.84e-05	0.000238	CcSEcCtD
Estropipate—Mental disorder—Epirubicin—uterine cancer	2.81e-05	0.000236	CcSEcCtD
Estropipate—Erythema multiforme—Doxorubicin—uterine cancer	2.81e-05	0.000236	CcSEcCtD
Estropipate—Erythema—Epirubicin—uterine cancer	2.79e-05	0.000235	CcSEcCtD
Estropipate—Malnutrition—Epirubicin—uterine cancer	2.79e-05	0.000235	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	2.79e-05	0.00172	CbGpPWpGaD
Estropipate—Diarrhoea—Etoposide—uterine cancer	2.78e-05	0.000234	CcSEcCtD
Estropipate—Eye disorder—Doxorubicin—uterine cancer	2.78e-05	0.000233	CcSEcCtD
Estropipate—Cardiac disorder—Doxorubicin—uterine cancer	2.76e-05	0.000232	CcSEcCtD
Estropipate—Flatulence—Epirubicin—uterine cancer	2.75e-05	0.000231	CcSEcCtD
Estropipate—Tension—Epirubicin—uterine cancer	2.74e-05	0.00023	CcSEcCtD
Estropipate—Nervousness—Epirubicin—uterine cancer	2.71e-05	0.000228	CcSEcCtD
Estropipate—Back pain—Epirubicin—uterine cancer	2.7e-05	0.000227	CcSEcCtD
Estropipate—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	2.7e-05	0.00167	CbGpPWpGaD
Estropipate—Angiopathy—Doxorubicin—uterine cancer	2.7e-05	0.000226	CcSEcCtD
Estropipate—Dizziness—Etoposide—uterine cancer	2.69e-05	0.000226	CcSEcCtD
Estropipate—Muscle spasms—Epirubicin—uterine cancer	2.69e-05	0.000226	CcSEcCtD
Estropipate—Immune system disorder—Doxorubicin—uterine cancer	2.68e-05	0.000225	CcSEcCtD
Estropipate—Mediastinal disorder—Doxorubicin—uterine cancer	2.68e-05	0.000225	CcSEcCtD
Estropipate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	2.65e-05	0.00164	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	2.63e-05	0.00163	CbGpPWpGaD
Estropipate—Alopecia—Doxorubicin—uterine cancer	2.62e-05	0.000221	CcSEcCtD
Estropipate—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	2.62e-05	0.00162	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—ESR1—uterine cancer	2.61e-05	0.00161	CbGpPWpGaD
Estropipate—Mental disorder—Doxorubicin—uterine cancer	2.6e-05	0.000219	CcSEcCtD
Estropipate—Vomiting—Etoposide—uterine cancer	2.59e-05	0.000217	CcSEcCtD
Estropipate—Erythema—Doxorubicin—uterine cancer	2.59e-05	0.000217	CcSEcCtD
Estropipate—Malnutrition—Doxorubicin—uterine cancer	2.59e-05	0.000217	CcSEcCtD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	2.58e-05	0.00159	CbGpPWpGaD
Estropipate—Rash—Etoposide—uterine cancer	2.57e-05	0.000216	CcSEcCtD
Estropipate—Dermatitis—Etoposide—uterine cancer	2.56e-05	0.000215	CcSEcCtD
Estropipate—Headache—Etoposide—uterine cancer	2.55e-05	0.000214	CcSEcCtD
Estropipate—Flatulence—Doxorubicin—uterine cancer	2.55e-05	0.000214	CcSEcCtD
Estropipate—Tension—Doxorubicin—uterine cancer	2.54e-05	0.000213	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—TP53—uterine cancer	2.53e-05	0.00156	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.53e-05	0.00156	CbGpPWpGaD
Estropipate—Nervousness—Doxorubicin—uterine cancer	2.51e-05	0.000211	CcSEcCtD
Estropipate—Vertigo—Epirubicin—uterine cancer	2.51e-05	0.000211	CcSEcCtD
Estropipate—Back pain—Doxorubicin—uterine cancer	2.5e-05	0.00021	CcSEcCtD
Estropipate—Muscle spasms—Doxorubicin—uterine cancer	2.49e-05	0.000209	CcSEcCtD
Estropipate—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	2.48e-05	0.00153	CbGpPWpGaD
Estropipate—Palpitations—Epirubicin—uterine cancer	2.47e-05	0.000207	CcSEcCtD
Estropipate—ESR1—Generic Transcription Pathway—PGR—uterine cancer	2.47e-05	0.00152	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	2.45e-05	0.00151	CbGpPWpGaD
Estropipate—Cough—Epirubicin—uterine cancer	2.44e-05	0.000205	CcSEcCtD
Estropipate—Nausea—Etoposide—uterine cancer	2.42e-05	0.000203	CcSEcCtD
Estropipate—ESR1—Gene Expression—SUZ12—uterine cancer	2.39e-05	0.00147	CbGpPWpGaD
Estropipate—Arthralgia—Epirubicin—uterine cancer	2.38e-05	0.0002	CcSEcCtD
Estropipate—Myalgia—Epirubicin—uterine cancer	2.38e-05	0.0002	CcSEcCtD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	2.38e-05	0.00147	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	2.38e-05	0.00147	CbGpPWpGaD
Estropipate—Anxiety—Epirubicin—uterine cancer	2.37e-05	0.000199	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	2.36e-05	0.000199	CcSEcCtD
Estropipate—ESR2—Gene Expression—PGR—uterine cancer	2.36e-05	0.00145	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—ERBB2—uterine cancer	2.34e-05	0.00144	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.32e-05	0.00143	CbGpPWpGaD
Estropipate—Vertigo—Doxorubicin—uterine cancer	2.32e-05	0.000195	CcSEcCtD
Estropipate—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	2.32e-05	0.00143	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	2.31e-05	0.00143	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—HRAS—uterine cancer	2.29e-05	0.00141	CbGpPWpGaD
Estropipate—Palpitations—Doxorubicin—uterine cancer	2.29e-05	0.000192	CcSEcCtD
Estropipate—Anaphylactic shock—Epirubicin—uterine cancer	2.28e-05	0.000192	CcSEcCtD
Estropipate—Oedema—Epirubicin—uterine cancer	2.28e-05	0.000192	CcSEcCtD
Estropipate—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.28e-05	0.0014	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.28e-05	0.0014	CbGpPWpGaD
Estropipate—Infection—Epirubicin—uterine cancer	2.27e-05	0.00019	CcSEcCtD
Estropipate—Cough—Doxorubicin—uterine cancer	2.26e-05	0.00019	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.25e-05	0.00139	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—EZH2—uterine cancer	2.24e-05	0.00138	CbGpPWpGaD
Estropipate—Nervous system disorder—Epirubicin—uterine cancer	2.24e-05	0.000188	CcSEcCtD
Estropipate—Skin disorder—Epirubicin—uterine cancer	2.22e-05	0.000186	CcSEcCtD
Estropipate—Arthralgia—Doxorubicin—uterine cancer	2.2e-05	0.000185	CcSEcCtD
Estropipate—Myalgia—Doxorubicin—uterine cancer	2.2e-05	0.000185	CcSEcCtD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	2.2e-05	0.00136	CbGpPWpGaD
Estropipate—Anxiety—Doxorubicin—uterine cancer	2.19e-05	0.000184	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—AKT1—uterine cancer	2.19e-05	0.00135	CbGpPWpGaD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	2.19e-05	0.000184	CcSEcCtD
Estropipate—ESR1—Generic Transcription Pathway—ESR2—uterine cancer	2.17e-05	0.00134	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—CDKN1B—uterine cancer	2.17e-05	0.00134	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	2.16e-05	0.00133	CbGpPWpGaD
Estropipate—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	2.14e-05	0.00132	CbGpPWpGaD
Estropipate—Oedema—Doxorubicin—uterine cancer	2.11e-05	0.000177	CcSEcCtD
Estropipate—Anaphylactic shock—Doxorubicin—uterine cancer	2.11e-05	0.000177	CcSEcCtD
Estropipate—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	2.11e-05	0.0013	CbGpPWpGaD
Estropipate—Infection—Doxorubicin—uterine cancer	2.1e-05	0.000176	CcSEcCtD
Estropipate—SLC22A1—Metabolism—NDUFB11—uterine cancer	2.1e-05	0.00129	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—SRD5A2—uterine cancer	2.1e-05	0.00129	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	2.09e-05	0.00129	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	2.09e-05	0.00129	CbGpPWpGaD
Estropipate—Musculoskeletal discomfort—Epirubicin—uterine cancer	2.08e-05	0.000175	CcSEcCtD
Estropipate—Nervous system disorder—Doxorubicin—uterine cancer	2.07e-05	0.000174	CcSEcCtD
Estropipate—Insomnia—Epirubicin—uterine cancer	2.06e-05	0.000173	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	2.06e-05	0.00127	CbGpPWpGaD
Estropipate—Skin disorder—Doxorubicin—uterine cancer	2.05e-05	0.000172	CcSEcCtD
Estropipate—Paraesthesia—Epirubicin—uterine cancer	2.05e-05	0.000172	CcSEcCtD
Estropipate—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	2.03e-05	0.00125	CbGpPWpGaD
Estropipate—Somnolence—Epirubicin—uterine cancer	2.03e-05	0.00017	CcSEcCtD
Estropipate—ESR1—Leptin signaling pathway—AKT1—uterine cancer	2.02e-05	0.00125	CbGpPWpGaD
Estropipate—Dyspepsia—Epirubicin—uterine cancer	2.01e-05	0.000169	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	2e-05	0.00124	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—PTEN—uterine cancer	1.99e-05	0.00123	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	1.98e-05	0.00122	CbGpPWpGaD
Estropipate—Gastrointestinal disorder—Epirubicin—uterine cancer	1.97e-05	0.000165	CcSEcCtD
Estropipate—Fatigue—Epirubicin—uterine cancer	1.97e-05	0.000165	CcSEcCtD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	1.95e-05	0.00121	CbGpPWpGaD
Estropipate—Pain—Epirubicin—uterine cancer	1.95e-05	0.000164	CcSEcCtD
Estropipate—Constipation—Epirubicin—uterine cancer	1.95e-05	0.000164	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.95e-05	0.0012	CbGpPWpGaD
Estropipate—Musculoskeletal discomfort—Doxorubicin—uterine cancer	1.92e-05	0.000162	CcSEcCtD
Estropipate—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	1.91e-05	0.00118	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—EP300—uterine cancer	1.91e-05	0.00118	CbGpPWpGaD
Estropipate—Insomnia—Doxorubicin—uterine cancer	1.91e-05	0.00016	CcSEcCtD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.9e-05	0.00117	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.9e-05	0.00117	CbGpPWpGaD
Estropipate—Paraesthesia—Doxorubicin—uterine cancer	1.9e-05	0.000159	CcSEcCtD
Estropipate—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	1.89e-05	0.00116	CbGpPWpGaD
Estropipate—Somnolence—Doxorubicin—uterine cancer	1.88e-05	0.000158	CcSEcCtD
Estropipate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	1.87e-05	0.00115	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Epirubicin—uterine cancer	1.87e-05	0.000157	CcSEcCtD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.86e-05	0.00115	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.86e-05	0.00115	CbGpPWpGaD
Estropipate—Dyspepsia—Doxorubicin—uterine cancer	1.86e-05	0.000156	CcSEcCtD
Estropipate—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	1.82e-05	0.00113	CbGpPWpGaD
Estropipate—Gastrointestinal disorder—Doxorubicin—uterine cancer	1.82e-05	0.000153	CcSEcCtD
Estropipate—Fatigue—Doxorubicin—uterine cancer	1.82e-05	0.000153	CcSEcCtD
Estropipate—ALB—Platelet degranulation—VEGFA—uterine cancer	1.82e-05	0.00112	CbGpPWpGaD
Estropipate—Urticaria—Epirubicin—uterine cancer	1.81e-05	0.000152	CcSEcCtD
Estropipate—ESR1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	1.81e-05	0.00112	CbGpPWpGaD
Estropipate—Pain—Doxorubicin—uterine cancer	1.8e-05	0.000152	CcSEcCtD
Estropipate—Constipation—Doxorubicin—uterine cancer	1.8e-05	0.000152	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.8e-05	0.00111	CbGpPWpGaD
Estropipate—Body temperature increased—Epirubicin—uterine cancer	1.8e-05	0.000151	CcSEcCtD
Estropipate—Abdominal pain—Epirubicin—uterine cancer	1.8e-05	0.000151	CcSEcCtD
Estropipate—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	1.8e-05	0.00111	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	1.78e-05	0.0011	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—NRAS—uterine cancer	1.78e-05	0.0011	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—CDKN2B—uterine cancer	1.77e-05	0.00109	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	1.73e-05	0.00107	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Doxorubicin—uterine cancer	1.73e-05	0.000145	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.7e-05	0.00105	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—CDKN2B—uterine cancer	1.69e-05	0.00104	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	1.68e-05	0.00104	CbGpPWpGaD
Estropipate—Hypersensitivity—Epirubicin—uterine cancer	1.68e-05	0.000141	CcSEcCtD
Estropipate—Urticaria—Doxorubicin—uterine cancer	1.68e-05	0.000141	CcSEcCtD
Estropipate—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.67e-05	0.00103	CbGpPWpGaD
Estropipate—Body temperature increased—Doxorubicin—uterine cancer	1.67e-05	0.00014	CcSEcCtD
Estropipate—Abdominal pain—Doxorubicin—uterine cancer	1.67e-05	0.00014	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.66e-05	0.00102	CbGpPWpGaD
Estropipate—Asthenia—Epirubicin—uterine cancer	1.64e-05	0.000137	CcSEcCtD
Estropipate—ESR1—Generic Transcription Pathway—SMAD3—uterine cancer	1.62e-05	0.000997	CbGpPWpGaD
Estropipate—Pruritus—Epirubicin—uterine cancer	1.61e-05	0.000136	CcSEcCtD
Estropipate—ALB—Folate Metabolism—TP53—uterine cancer	1.6e-05	0.000988	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.59e-05	0.000982	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.59e-05	0.000982	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.58e-05	0.000977	CbGpPWpGaD
Estropipate—Diarrhoea—Epirubicin—uterine cancer	1.56e-05	0.000131	CcSEcCtD
Estropipate—Hypersensitivity—Doxorubicin—uterine cancer	1.55e-05	0.000131	CcSEcCtD
Estropipate—ESR2—Gene Expression—SMAD3—uterine cancer	1.54e-05	0.000951	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.54e-05	0.00095	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—KRAS—uterine cancer	1.53e-05	0.000945	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—STAR—uterine cancer	1.51e-05	0.000935	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—AKR1B1—uterine cancer	1.51e-05	0.000935	CbGpPWpGaD
Estropipate—Asthenia—Doxorubicin—uterine cancer	1.51e-05	0.000127	CcSEcCtD
Estropipate—ESR1—Signaling Pathways—AKR1B10—uterine cancer	1.51e-05	0.000931	CbGpPWpGaD
Estropipate—Dizziness—Epirubicin—uterine cancer	1.51e-05	0.000127	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.5e-05	0.000925	CbGpPWpGaD
Estropipate—Pruritus—Doxorubicin—uterine cancer	1.49e-05	0.000125	CcSEcCtD
Estropipate—Vomiting—Epirubicin—uterine cancer	1.45e-05	0.000122	CcSEcCtD
Estropipate—Diarrhoea—Doxorubicin—uterine cancer	1.44e-05	0.000121	CcSEcCtD
Estropipate—Rash—Epirubicin—uterine cancer	1.44e-05	0.000121	CcSEcCtD
Estropipate—Dermatitis—Epirubicin—uterine cancer	1.44e-05	0.000121	CcSEcCtD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	1.43e-05	0.000882	CbGpPWpGaD
Estropipate—Headache—Epirubicin—uterine cancer	1.43e-05	0.00012	CcSEcCtD
Estropipate—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.41e-05	0.000869	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—PIK3CA—uterine cancer	1.41e-05	0.000868	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IRF1—uterine cancer	1.4e-05	0.000867	CbGpPWpGaD
Estropipate—ALB—Metabolism—SRD5A2—uterine cancer	1.4e-05	0.000865	CbGpPWpGaD
Estropipate—ALB—Metabolism—NDUFB11—uterine cancer	1.4e-05	0.000865	CbGpPWpGaD
Estropipate—Dizziness—Doxorubicin—uterine cancer	1.4e-05	0.000117	CcSEcCtD
Estropipate—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.39e-05	0.000857	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.37e-05	0.000844	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.37e-05	0.000843	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.36e-05	0.00084	CbGpPWpGaD
Estropipate—Nausea—Epirubicin—uterine cancer	1.35e-05	0.000114	CcSEcCtD
Estropipate—Vomiting—Doxorubicin—uterine cancer	1.34e-05	0.000113	CcSEcCtD
Estropipate—Rash—Doxorubicin—uterine cancer	1.33e-05	0.000112	CcSEcCtD
Estropipate—Dermatitis—Doxorubicin—uterine cancer	1.33e-05	0.000112	CcSEcCtD
Estropipate—Headache—Doxorubicin—uterine cancer	1.32e-05	0.000111	CcSEcCtD
Estropipate—ESR1—Signaling by ERBB4—HRAS—uterine cancer	1.3e-05	0.000803	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.29e-05	0.000793	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.28e-05	0.000787	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—ESR1—uterine cancer	1.26e-05	0.000776	CbGpPWpGaD
Estropipate—Nausea—Doxorubicin—uterine cancer	1.25e-05	0.000105	CcSEcCtD
Estropipate—ESR1—Signaling Pathways—RNF43—uterine cancer	1.25e-05	0.000772	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—POLD1—uterine cancer	1.19e-05	0.000733	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PGR—uterine cancer	1.19e-05	0.000733	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.17e-05	0.000723	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.17e-05	0.000721	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.15e-05	0.000713	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—AKT1—uterine cancer	1.15e-05	0.000709	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.15e-05	0.000708	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.15e-05	0.000708	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—INHBA—uterine cancer	1.14e-05	0.000706	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.13e-05	0.000699	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—EZH2—uterine cancer	1.13e-05	0.000696	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.11e-05	0.000688	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—AKR1C1—uterine cancer	1.11e-05	0.000686	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.05e-05	0.000649	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—ESR2—uterine cancer	1.05e-05	0.000646	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AKR1C1—uterine cancer	1.03e-05	0.000635	CbGpPWpGaD
Estropipate—ALB—Metabolism—AKR1B1—uterine cancer	1.01e-05	0.000625	CbGpPWpGaD
Estropipate—ALB—Metabolism—STAR—uterine cancer	1.01e-05	0.000625	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1e-05	0.000618	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—RRM2—uterine cancer	9.91e-06	0.000611	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SRD5A2—uterine cancer	9.8e-06	0.000605	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NDUFB11—uterine cancer	9.8e-06	0.000605	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—DCN—uterine cancer	9.62e-06	0.000594	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	9.57e-06	0.000591	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	9.52e-06	0.000588	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—HRAS—uterine cancer	9.43e-06	0.000582	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP11A1—uterine cancer	9.06e-06	0.000559	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	8.99e-06	0.000555	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—AKR1C3—uterine cancer	8.56e-06	0.000528	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—CDKN2B—uterine cancer	8.52e-06	0.000525	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AKR1B1—uterine cancer	8.29e-06	0.000512	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—STAR—uterine cancer	8.29e-06	0.000512	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	8.2e-06	0.000506	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	8.06e-06	0.000497	CbGpPWpGaD
Estropipate—ALB—Metabolism—POLD1—uterine cancer	7.95e-06	0.000491	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AKR1C3—uterine cancer	7.93e-06	0.000489	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—SMAD3—uterine cancer	7.78e-06	0.00048	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PGR—uterine cancer	7.73e-06	0.000477	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NDUFB11—uterine cancer	7.57e-06	0.000467	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SRD5A2—uterine cancer	7.57e-06	0.000467	CbGpPWpGaD
Estropipate—ALB—Metabolism—AKR1C1—uterine cancer	7.44e-06	0.000459	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—YWHAE—uterine cancer	7.37e-06	0.000455	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—HRAS—uterine cancer	7.23e-06	0.000446	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKR1B1—uterine cancer	7.09e-06	0.000437	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—STAR—uterine cancer	7.09e-06	0.000437	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FBXW7—uterine cancer	7.07e-06	0.000436	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.01e-06	0.000432	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—STK11—uterine cancer	6.67e-06	0.000411	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP19A1—uterine cancer	6.67e-06	0.000411	CbGpPWpGaD
Estropipate—ALB—Metabolism—RRM2—uterine cancer	6.63e-06	0.000409	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—POLD1—uterine cancer	6.51e-06	0.000402	CbGpPWpGaD
Estropipate—ALB—Metabolism—DCN—uterine cancer	6.44e-06	0.000397	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	6.29e-06	0.000388	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—STK11—uterine cancer	6.18e-06	0.000381	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AKR1C1—uterine cancer	6.09e-06	0.000376	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP11A1—uterine cancer	6.06e-06	0.000374	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SOCS3—uterine cancer	5.78e-06	0.000357	CbGpPWpGaD
Estropipate—ALB—Metabolism—AKR1C3—uterine cancer	5.73e-06	0.000353	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—POLD1—uterine cancer	5.56e-06	0.000343	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN2B—uterine cancer	5.54e-06	0.000342	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKR1B1—uterine cancer	5.47e-06	0.000338	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—STAR—uterine cancer	5.47e-06	0.000338	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—RRM2—uterine cancer	5.43e-06	0.000335	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IGF1R—uterine cancer	5.38e-06	0.000332	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—DCN—uterine cancer	5.27e-06	0.000325	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKR1C1—uterine cancer	5.2e-06	0.000321	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	5.14e-06	0.000317	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SMAD3—uterine cancer	5.06e-06	0.000312	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—MTHFR—uterine cancer	5.01e-06	0.000309	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP11A1—uterine cancer	4.96e-06	0.000306	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FGFR2—uterine cancer	4.82e-06	0.000298	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AKR1C3—uterine cancer	4.69e-06	0.000289	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—RRM2—uterine cancer	4.64e-06	0.000286	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—AKT1—uterine cancer	4.54e-06	0.00028	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—DCN—uterine cancer	4.5e-06	0.000278	CbGpPWpGaD
Estropipate—ALB—Metabolism—STK11—uterine cancer	4.46e-06	0.000275	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP19A1—uterine cancer	4.46e-06	0.000275	CbGpPWpGaD
Estropipate—ALB—Hemostasis—EP300—uterine cancer	4.39e-06	0.000271	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—POLD1—uterine cancer	4.29e-06	0.000265	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP11A1—uterine cancer	4.24e-06	0.000262	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.19e-06	0.000258	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VEGFA—uterine cancer	4.15e-06	0.000256	CbGpPWpGaD
Estropipate—ALB—Hemostasis—NRAS—uterine cancer	4.1e-06	0.000253	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKR1C1—uterine cancer	4.02e-06	0.000248	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKR1C3—uterine cancer	4.01e-06	0.000247	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.99e-06	0.000246	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP19A1—uterine cancer	3.65e-06	0.000225	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—STK11—uterine cancer	3.65e-06	0.000225	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCL2—uterine cancer	3.63e-06	0.000224	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—RRM2—uterine cancer	3.58e-06	0.000221	CbGpPWpGaD
Estropipate—ALB—Hemostasis—KRAS—uterine cancer	3.53e-06	0.000218	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—DCN—uterine cancer	3.47e-06	0.000214	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.43e-06	0.000211	CbGpPWpGaD
Estropipate—ALB—Metabolism—MTHFR—uterine cancer	3.35e-06	0.000207	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP11A1—uterine cancer	3.27e-06	0.000202	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.27e-06	0.000202	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CA—uterine cancer	3.24e-06	0.0002	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—uterine cancer	3.14e-06	0.000194	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP19A1—uterine cancer	3.12e-06	0.000193	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—STK11—uterine cancer	3.12e-06	0.000193	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.09e-06	0.000191	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ERBB2—uterine cancer	3.03e-06	0.000187	CbGpPWpGaD
Estropipate—ALB—Hemostasis—HRAS—uterine cancer	3e-06	0.000185	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.95e-06	0.000182	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.93e-06	0.000181	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCL8—uterine cancer	2.87e-06	0.000177	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN1B—uterine cancer	2.8e-06	0.000173	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.79e-06	0.000172	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTEN—uterine cancer	2.79e-06	0.000172	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—MTHFR—uterine cancer	2.74e-06	0.000169	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—EP300—uterine cancer	2.66e-06	0.000164	CbGpPWpGaD
Estropipate—ALB—Hemostasis—AKT1—uterine cancer	2.65e-06	0.000164	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CTNNB1—uterine cancer	2.65e-06	0.000163	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTEN—uterine cancer	2.58e-06	0.000159	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EP300—uterine cancer	2.46e-06	0.000152	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.42e-06	0.000149	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.41e-06	0.000149	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—STK11—uterine cancer	2.41e-06	0.000149	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—MTHFR—uterine cancer	2.34e-06	0.000145	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VEGFA—uterine cancer	2.33e-06	0.000144	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NRAS—uterine cancer	2.3e-06	0.000142	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—AKT1—uterine cancer	2.29e-06	0.000141	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.07e-06	0.000127	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KRAS—uterine cancer	1.98e-06	0.000122	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CA—uterine cancer	1.97e-06	0.000121	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTEN—uterine cancer	1.86e-06	0.000115	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CA—uterine cancer	1.82e-06	0.000112	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—MTHFR—uterine cancer	1.81e-06	0.000112	CbGpPWpGaD
Estropipate—ALB—Metabolism—EP300—uterine cancer	1.78e-06	0.00011	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—uterine cancer	1.76e-06	0.000109	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HRAS—uterine cancer	1.69e-06	0.000104	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—AKT1—uterine cancer	1.61e-06	9.91e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTEN—uterine cancer	1.53e-06	9.42e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AKT1—uterine cancer	1.49e-06	9.18e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—EP300—uterine cancer	1.46e-06	8.98e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CA—uterine cancer	1.32e-06	8.12e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTEN—uterine cancer	1.3e-06	8.05e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—EP300—uterine cancer	1.24e-06	7.68e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.08e-06	6.64e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—AKT1—uterine cancer	1.07e-06	6.63e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTEN—uterine cancer	1.01e-06	6.21e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—EP300—uterine cancer	9.6e-07	5.92e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CA—uterine cancer	9.2e-07	5.68e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AKT1—uterine cancer	8.8e-07	5.43e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKT1—uterine cancer	7.52e-07	4.64e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CA—uterine cancer	7.1e-07	4.38e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKT1—uterine cancer	5.8e-07	3.58e-05	CbGpPWpGaD
